Packaged Foods
Build Your Comparison
Side-by-side financial analysisStock Comparison
NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Industrial - Pollution & Treatment Controls
Security & Protection Services
Regulated Water
Banks - Diversified
NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Packaged Foods | Hardware, Equipment & Parts | Industrial - Pollution & Treatment Controls | Security & Protection Services | Regulated Water | Banks - Diversified |
| Market Cap | $2M | $3.55B | $413M | $4.73B | $992M | $842.21B |
| Revenue (TTM) | $11M | $2.35B | $136M | $7.61B | $199M | $270.79B |
| Net Income (TTM) | $-4M | $289M | $21M | $-495M | $44M | $58.03B |
| Gross Margin | 1.4% | 38.6% | 64.3% | 27.8% | 33.3% | 58.6% |
| Operating Margin | -25.2% | 13.2% | 19.9% | 8.3% | 28.1% | 27.7% |
| Forward P/E | — | 13.4x | 19.1x | 10.8x | 21.2x | 14.0x |
| Total Debt | $7M | $1.29B | $9M | $3.17B | $419M | $751.15B |
| Cash & Equiv. | $8M | $1.02B | $48M | $661M | $3M | $469.32B |
NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | Jun 26 | Return |
|---|---|---|---|
| Nocera, Inc. (NCRA) | 100 | 3.7 | -96.3% |
| Itron, Inc. (ITRI) | 100 | 93.1 | -6.9% |
| Energy Recovery, In… (ERII) | 100 | 57.9 | -42.1% |
| Resideo Technologie… (REZI) | 100 | 135.1 | +35.1% |
| Middlesex Water Com… (MSEX) | 100 | 67.0 | -33.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 242.8 | +142.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 6 stocks, NCRA doesn't own a clear edge in any measured category.
ITRI is the clearest fit if your priority is growth exposure.
- Rev growth -3.0%, EPS growth 25.7%, 3Y rev CAGR 9.7%
ERII is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.60, Low D/E 4.6%, current ratio 10.44x
- 9.6% ROA vs NCRA's -52.5%, ROIC 10.3% vs -70.0%
REZI has the current edge in this matchup, primarily because of its strength in value and momentum.
- Lower P/E (10.8x vs 21.2x)
- +49.3% vs NCRA's -83.7%
MSEX is the #2 pick in this set and the best alternative if quality and dividends is your priority.
- 22.1% margin vs NCRA's -34.0%
- 2.6% yield, 22-year raise streak, vs JPM's 1.6%, (3 stocks pay no dividend)
JPM ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.95, yield 1.6%
- 435.6% 10Y total return vs ITRI's 77.4%
- PEG 1.08 vs MSEX's 13.24
- Beta 0.95, yield 1.6%, current ratio 0.65x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.6% NII/revenue growth vs NCRA's -35.2% | |
| Value | Lower P/E (10.8x vs 21.2x) | |
| Quality / Margins | 22.1% margin vs NCRA's -34.0% | |
| Stability / Safety | Beta 0.95 vs REZI's 2.16 | |
| Dividends | 2.6% yield, 22-year raise streak, vs JPM's 1.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +49.3% vs NCRA's -83.7% | |
| Efficiency (ROA) | 9.6% ROA vs NCRA's -52.5%, ROIC 10.3% vs -70.0% |
NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ERII leads in 1 of 6 categories
REZI leads 1 • ITRI leads 1 • JPM leads 1 • MSEX leads 1 • NCRA leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ERII leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $270.8B annually — 23812.7x NCRA's $11M. MSEX is the more profitable business, keeping 22.1% of every revenue dollar as net income compared to NCRA's -34.0%. On growth, ERII holds the edge at +20.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11M | $2.3B | $136M | $7.6B | $199M | $270.8B |
| EBITDAEarnings before interest/tax | -$3M | $367M | $39M | $828M | $81M | $81.3B |
| Net IncomeAfter-tax profit | -$4M | $289M | $21M | -$495M | $44M | $58.0B |
| Free Cash FlowCash after capex | -$3M | $393M | $27M | -$1.3B | -$19M | -$119.7B |
| Gross MarginGross profit ÷ Revenue | +1.4% | +38.6% | +64.3% | +27.8% | +33.3% | +58.6% |
| Operating MarginEBIT ÷ Revenue | -25.2% | +13.2% | +19.9% | +8.3% | +28.1% | +27.7% |
| Net MarginNet income ÷ Revenue | -34.0% | +12.3% | +15.1% | -6.5% | +22.1% | +21.6% |
| FCF MarginFCF ÷ Revenue | -26.9% | +16.7% | +19.9% | -17.6% | -9.7% | -15.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -49.8% | -3.3% | +20.3% | +8.0% | +10.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -3.9% | -16.9% | -27.8% | +9.5% | -100.0% | +16.0% |
Valuation Metrics
REZI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, ITRI trades at a 46% valuation discount to MSEX's 22.6x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 1.22x vs MSEX's 14.14x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $2M | $3.5B | $413M | $4.7B | $992M | $842.2B |
| Enterprise ValueMkt cap + debt − cash | $2M | $3.8B | $374M | $7.2B | $1.4B | $1.12T |
| Trailing P/EPrice ÷ TTM EPS | -0.84x | 12.30x | 19.07x | -8.28x | 22.61x | 15.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 13.36x | — | 10.76x | 21.18x | 14.03x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 14.14x | 1.22x |
| EV / EBITDAEnterprise value multiple | — | 10.35x | 13.22x | 8.65x | 16.21x | 13.54x |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 1.50x | 3.07x | 0.63x | 5.09x | 3.11x |
| Price / BookPrice ÷ Book value/share | 1.09x | 2.12x | 2.10x | 1.59x | 1.96x | 2.61x |
| Price / FCFMarket cap ÷ FCF | — | 9.32x | 23.67x | — | — | — |
Profitability & Efficiency
ITRI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ITRI delivers a 17.2% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-132 for NCRA. ERII carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to NCRA's 3.31x. On the Piotroski fundamental quality scale (0–9), ITRI scores 7/9 vs REZI's 3/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -132.0% | +17.2% | +10.9% | -17.6% | +9.1% | +16.1% |
| ROA (TTM)Return on assets | -52.5% | +7.7% | +9.6% | -5.9% | +3.2% | +1.3% |
| ROICReturn on invested capital | -70.0% | +13.1% | +10.3% | +9.5% | +4.7% | +5.4% |
| ROCEReturn on capital employed | -35.9% | +11.4% | +11.3% | +9.8% | +4.4% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 6 | 3 | 4 | 5 |
| Debt / EquityFinancial leverage | 3.31x | 0.74x | 0.05x | 1.09x | 0.85x | 2.18x |
| Net DebtTotal debt minus cash | -$697,307 | $267M | -$39M | $2.5B | $416M | $281.8B |
| Cash & Equiv.Liquid assets | $8M | $1.0B | $48M | $661M | $3M | $469.3B |
| Total DebtShort + long-term debt | $7M | $1.3B | $9M | $3.2B | $419M | $751.1B |
| Interest CoverageEBIT ÷ Interest expense | — | 14.38x | — | 3.98x | 4.33x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $20,251 today (with dividends reinvested), compared to $343 for NCRA. Over the past 12 months, REZI leads with a +49.3% total return vs NCRA's -83.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.0% vs NCRA's -51.6% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -80.3% | -15.2% | -41.6% | -11.2% | +7.6% | -3.1% |
| 1-Year ReturnPast 12 months | -83.7% | -33.0% | -35.7% | +49.3% | -2.5% | +21.5% |
| 3-Year ReturnCumulative with dividends | -88.7% | +16.1% | -68.5% | +88.2% | -29.7% | +135.5% |
| 5-Year ReturnCumulative with dividends | -96.6% | -16.3% | -59.2% | -2.8% | -31.9% | +102.5% |
| 10-Year ReturnCumulative with dividends | -97.4% | +77.4% | -26.8% | +7.6% | +70.8% | +435.6% |
| CAGR (3Y)Annualised 3-year return | -51.6% | +5.1% | -31.9% | +23.5% | -11.1% | +33.0% |
Risk & Volatility
Evenly matched — MSEX and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
MSEX is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than REZI's 2.16 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 92.6% from its 52-week high vs NCRA's 7.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 1.56x | 1.60x | 2.16x | -0.08x | 0.95x |
| 52-Week HighHighest price in past year | $2.40 | $142.00 | $18.32 | $45.29 | $62.18 | $337.25 |
| 52-Week LowLowest price in past year | $0.16 | $77.77 | $7.94 | $20.41 | $44.17 | $260.31 |
| % of 52W HighCurrent price vs 52-week peak | +7.0% | +56.4% | +43.7% | +68.9% | +85.8% | +92.6% |
| RSI (14)Momentum oscillator 0–100 | 40.8 | 42.4 | 39.0 | 39.5 | 52.5 | 58.4 |
| Avg Volume (50D)Average daily shares traded | 7.2M | 774K | 1.0M | 1.3M | 138K | 7.1M |
Analyst Outlook
MSEX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ITRI as "Hold", ERII as "Buy", REZI as "Buy", MSEX as "Buy", JPM as "Buy". Consensus price targets imply 70.9% upside for ITRI (target: $137) vs 3.1% for MSEX (target: $55). For income investors, MSEX offers the higher dividend yield at 2.57% vs REZI's 0.75%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $136.80 | $12.50 | $40.00 | $55.00 | $338.78 |
| # AnalystsCovering analysts | — | 37 | 16 | 7 | 4 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.8% | +2.6% | +1.6% |
| Dividend StreakConsecutive years of raises | — | 1 | — | 2 | 22 | 15 |
| Dividend / ShareAnnual DPS | — | — | — | $0.23 | $1.37 | $5.13 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.8% | +8.6% | +0.6% | 0.0% | +3.4% |
ERII leads in 1 of 6 categories (Income & Cash Flow). REZI leads in 1 (Valuation Metrics). 1 tied.
NCRA vs ITRI vs ERII vs REZI vs MSEX vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NCRA or ITRI or ERII or REZI or MSEX or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 14. 6% revenue growth year-over-year, versus -35. 2% for Nocera, Inc. (NCRA). Itron, Inc. (ITRI) offers the better valuation at 12. 3x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate Energy Recovery, Inc. (ERII) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NCRA or ITRI or ERII or REZI or MSEX or JPM?
On trailing P/E, Itron, Inc.
(ITRI) is the cheapest at 12. 3x versus Middlesex Water Company at 22. 6x. On forward P/E, Resideo Technologies, Inc. is actually cheaper at 10. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 1. 08x versus Middlesex Water Company's 13. 24x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NCRA or ITRI or ERII or REZI or MSEX or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +102. 5%, compared to -96. 6% for Nocera, Inc. (NCRA). Over 10 years, the gap is even starker: JPM returned +435. 6% versus NCRA's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NCRA or ITRI or ERII or REZI or MSEX or JPM?
By beta (market sensitivity over 5 years), Middlesex Water Company (MSEX) is the lower-risk stock at -0.
08β versus Resideo Technologies, Inc. 's 2. 16β — meaning REZI is approximately -2928% more volatile than MSEX relative to the S&P 500. On balance sheet safety, Energy Recovery, Inc. (ERII) carries a lower debt/equity ratio of 5% versus 3% for Nocera, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NCRA or ITRI or ERII or REZI or MSEX or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 14. 6% versus -35. 2% for Nocera, Inc. (NCRA). On earnings-per-share growth, the picture is similar: Itron, Inc. grew EPS 25. 7% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, ITRI leads at 9. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NCRA or ITRI or ERII or REZI or MSEX or JPM?
Middlesex Water Company (MSEX) is the more profitable company, earning 22.
0% net margin versus -25. 7% for Nocera, Inc. — meaning it keeps 22. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSEX leads at 27. 9% versus -22. 3% for NCRA. At the gross margin level — before operating expenses — ERII leads at 65. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NCRA or ITRI or ERII or REZI or MSEX or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 1. 08x versus Middlesex Water Company's 13. 24x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Resideo Technologies, Inc. (REZI) trades at 10. 8x forward P/E versus 21. 2x for Middlesex Water Company — 10. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 70. 9% to $136. 80.
08Which pays a better dividend — NCRA or ITRI or ERII or REZI or MSEX or JPM?
In this comparison, MSEX (2.
6% yield), JPM (1. 6% yield), REZI (0. 8% yield) pay a dividend. NCRA, ITRI, ERII do not pay a meaningful dividend and should not be held primarily for income.
09Is NCRA or ITRI or ERII or REZI or MSEX or JPM better for a retirement portfolio?
For long-horizon retirement investors, Middlesex Water Company (MSEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
08), 2. 6% yield). Nocera, Inc. (NCRA) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSEX: +70. 8%, NCRA: -97. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NCRA and ITRI and ERII and REZI and MSEX and JPM?
These companies operate in different sectors (NCRA (Consumer Defensive) and ITRI (Technology) and ERII (Industrials) and REZI (Industrials) and MSEX (Utilities) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NCRA is a small-cap quality compounder stock; ITRI is a small-cap deep-value stock; ERII is a small-cap quality compounder stock; REZI is a small-cap quality compounder stock; MSEX is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. REZI, MSEX, JPM pay a dividend while NCRA, ITRI, ERII do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.